Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 3/20 | 0.60 |
| ▸ | CHRM2 | P08172 | 1/20 | 0.44 |
| ▸ | CHRM4 | P08173 | 1/20 | 0.44 |
| ▸ | CHRM1 | P11229 | 1/20 | 0.44 |
| ▸ | TBXA2R | P21731 | 1/20 | 0.44 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.43 |
| ▸ | GALR3 | O60755 | 1/20 | 0.43 |
| ▸ | MAPT | P10636 | 1/20 | 0.43 |
| ▸ | BLM | P54132 | 1/20 | 0.43 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.33 |
| ▸ | MEN1 | O00255 | 1/20 | 0.33 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.33 |
| ▸ | HRH1 | P35367 | 1/20 | 0.33 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.33 |
| ▸ | LMNA | P02545 | 1/20 | 0.33 |
| ▸ | TRPV1 | Q8NER1 | 1/20 | 0.32 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.32 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.31 |
| ▸ | HCAR2 | Q8TDS4 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1460735 | 0.88 | TSHR (0.58) | TSHRCHRM2CHRM4CHRM1TBXA2R | |
| SCHEMBL987906 | 0.82 | TSHR (0.65) | TSHRCHRM2CHRM4CHRM1TBXA2R | |
| SCHEMBL17489303 | 0.81 | TSHR (0.50) | TSHRCHRM2CHRM4CHRM1TBXA2R | |
| SCHEMBL8420800 | 0.81 | TSHR (0.50) | TSHRCHRM2CHRM4CHRM1TBXA2R | |
| SCHEMBL3751956 | 0.81 | TSHR (0.50) | TSHRCHRM2CHRM4CHRM1TBXA2R | |
| SCHEMBL1270602 | 0.81 | TSHR (0.50) | TSHRCHRM2CHRM4CHRM1TBXA2R | |
| SCHEMBL7269317 | 0.80 | TSHR (0.82) | TSHRCHRM2CHRM4CHRM1TBXA2R | |
| SCHEMBL14365840 | 0.79 | TSHR (0.48) | TSHRCHRM2CHRM4CHRM1TBXA2R | |
| SCHEMBL3336017 | 0.79 | TSHR (0.48) | TSHRCHRM2CHRM4CHRM1TBXA2R | |
| SCHEMBL10340745 | 0.79 | TSHR (0.48) | TSHRCHRM2CHRM4CHRM1TBXA2R |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 51 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9688063-B2 | Method for forming an article having a decorative surface | 3M INNOVATIVE PROPERTIES COMPANY (US) | 2017-06-27 | — | — | US | claimed |
| US-20160193826-A1 | METHOD FOR FORMING AN ARTICLE HAVING A DECORATIVE SURFACE | 3M INNOVATIVE PROPERTIES COMPANY | 2016-07-07 | — | — | US | claimed |
| US-9290031-B2 | Method for forming an article having a decorative surface | 3M INNOVATIVE PROPERTIES COMPANY (US) | 2016-03-22 | — | — | US | claimed |
| CN-101389680-B | Method of forming an article having a decorative surface | 3M INNOVATION CO LTD | 2012-01-18 | — | — | CN | claimed |
| EP-1987076-B1 | METHOD FOR FORMING AN ARTICLE HAVING A DECORATIVE SURFACE | 3M INNOVATIVE PROPERTIES CO (US) | 2010-10-13 | — | — | EP | claimed |
| US-20100215918-A1 | METHOD FOR FORMING AN ARTICLE HAVING A DECORATIVE SURFACE | 3M INNOVATIVE PROPERTIES COMPANY (US) | 2010-08-26 | — | — | US | claimed |
| JP-2009527392-A | — | — | 2009-07-30 | — | — | JP | claimed |
| CN-101389680-A | Method of forming an article having a decorative surface | 3M INNOVATIVE PROPERTIES CO (US) | 2009-03-18 | — | — | CN | claimed |
| EP-1987076-A1 | METHOD FOR FORMING AN ARTICLE HAVING A DECORATIVE SURFACE | 3M Innovative Properties Company (US) | 2008-11-05 | — | — | EP | claimed |
| WO-2007100681-A1 | METHOD FOR FORMING AN ARTICLE HAVING A DECORATIVE SURFACE | 3M INNOVATIVE PROPERTIES COMPANY (US) | 2007-09-07 | — | — | WO | claimed |
| US-9688063-B2 | Method for forming an article having a decorative surface | 3M INNOVATIVE PROPERTIES COMPANY (US) | 2017-06-27 | — | — | US | disclosed |
| US-20170101431-A1 | NUCLEOSIDE DERIVATIVES FOR THE TREATMENT OF CANCER | IDENIX PHARMACEUTICALS LLC (US) | 2017-04-13 | — | — | US | disclosed |
| US-20160193826-A1 | METHOD FOR FORMING AN ARTICLE HAVING A DECORATIVE SURFACE | 3M INNOVATIVE PROPERTIES COMPANY | 2016-07-07 | — | — | US | disclosed |
| US-9290031-B2 | Method for forming an article having a decorative surface | 3M INNOVATIVE PROPERTIES COMPANY (US) | 2016-03-22 | — | — | US | disclosed |
| US-9188857-B2 | Resist polymer, process for production thereof, resist composition, and process for production of substrates with patterns thereon | MITSUBISHI RAYON CO., LTD. (JP) | 2015-11-17 | — | — | US | disclosed |
| US-5239112-A | Reacting vinyl ester and alcohol in solvent having specific dielectric constant using palladium or platinum catalyst | AIR PRODUCTS AND CHEMICALS, INC. (US) | 1993-08-24 | — | — | US | disclosed |
| US-5180851-A | PREPARATION OF N-(L-ALKOXYALKYL)FORMAMIDE AND ALKYLIDENE BISFORMAMIDES USING AMINE NEUTRALIZED ION EXCHANGE RESINS | AIR PRODUCTS AND CHEMICALS INC. (US) | 1993-01-19 | — | — | US | disclosed |
| US-5128234-A | PRODUCTION OF PHOTOPOLYMERIC FLEXOGRAPHIC RELIEF PRINTING PLATES | BASF AKTIENGESELLSCHAFT (DE) | 1992-07-07 | — | — | US | disclosed |
| US-5117056-A | From Acetals or Hemiacetal Esters | AIR PRODUCTS AND CHEMICALS, INC. (US) | 1992-05-26 | — | — | US | disclosed |
| EP-0418011-A2 | Photocurable compositions | SERICOL LIMITED (GB) | 1991-03-20 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20170101431-A1 | NUCLEOSIDE DERIVATIVES FOR THE TREATMENT OF CANCER | TYMP, NSUN2, PNP | TSHR 4772/4885CHRM2 4824/4885CHRM4 4806/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.